Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Rejuveinix by Reven for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Rejuveinix is under clinical development by Reven and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According to...
Data Insights
Rejuveinix by Reven for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Rejuveinix is under clinical development by Reven and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...